2-[(hydroxyamino)carbonyl]-4-methylphenyl 4-(2-butynyloxy)benzenesulfonate | 714961-75-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-[(hydroxyamino)carbonyl]-4-methylphenyl 4-(2-butynyloxy)benzenesulfonate
• 英文别名: [2-(Hydroxycarbamoyl)-4-methylphenyl] 4-but-2-ynoxybenzenesulfonate
• CAS: 714961-75-8
• 化学式: C₁₈H₁₇NO₆S
• 分子量: 375.402
• InChiKey: PLKSCRUWELTNDD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  26
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  110
• 氢给体数：
  2
• 氢受体数：
  6

文献信息

• Acetylenic aryl sulfonate hydroxamic acid TACE and matrix metalloproteinase inhibitors
  申请人：Wyeth Holdings Corporation

  公开号：US20040127524A1

  公开（公告）日：2004-07-01

  Hydroxamic acids having the formula 1 are useful in treating disease conditions mediated by TNF-□, such as rheumatoid arthritis, graft rejection, cachexia, inflammation, fever, insulin resistance, septic shock, congestive heart failure, inflammatory disease of the central nervous system, inflammatory bowel disease or HIV infection.

  具有公式1的羟甲酸在治疗由TNF-α介导的疾病情况中具有用处，例如类风湿性关节炎、移植排斥、虚弱、炎症、发热、胰岛素抵抗、脓毒性休克、充血性心力衰竭、中枢神经系统的炎症性疾病、炎症性肠病或HIV感染。
• Acetylenic aryl sulfonate hydroxamic acid tace and matrix metalloproteinase inhibitors
  申请人：Levin Ian Jeremy

  公开号：US20070155834A1

  公开（公告）日：2007-07-05

  Hydroxamic acids having the formula are useful in treating disease conditions mediated by TNF-□, such as rheumatoid arthritis, graft rejection, cachexia, inflammation, fever, insulin resistance, septic shock, congestive heart failure, inflammatory disease of the central nervous system, inflammatory bowel disease or HIV infection.

  具有以下化学式的羟肟酸对治疗由TNF-□介导的疾病条件具有用处，例如类风湿性关节炎、移植排斥、消瘦、炎症、发热、胰岛素抵抗、脓毒性休克、充血性心力衰竭、中枢神经系统炎症性疾病、炎症性肠病或HIV感染。
• US7199155B2
  申请人：——

  公开号：US7199155B2

  公开（公告）日：2007-04-03
• US7485667B2
  申请人：——

  公开号：US7485667B2

  公开（公告）日：2009-02-03
• [EN] ACETYLENIC ARYL SULFONATE HYDROXAMIC ACID TACE AND MATRIX METALLOPROTEINASE INHIBITORS<br/>[FR] TACE D'ACIDE HYDROXAMIQUE SULFONATE ARYLE ACETYLENE ET INHIBITEURS DE METALLOPROTEINASE MATRICIELLE
  申请人：WYETH CORP

  公开号：WO2005021489A2

  公开（公告）日：2005-03-10

  Hydroxamic acids having the formula (B) are useful in treating disease conditions mediated by TNF-(x, euch as rheumatoid arthritis, graft rejection, cachexia, inflammation, fever, insulin resistance, septic shock, congestive heart hHure, inflammatory disease of the central nervous system, inflammatory bowel disease or HIV infection.